Board of Directors

Magali HaasMagali Haas, MD, PhD
Board Chair

Dr. Haas founded Orion Bionetworks in July 2012 and serves as its CEO and President. Orion Bionetworks was transformed to Cohen Veterans Bioscience in 2015 to specifically dedicate research to improving the detection and treatment of post-traumatic stress (PTS) and traumatic brain injury (TBI) and related co-morbidities so that the burden of these conditions may be lessened on service members, veterans, and their families.

Magali has over 15 years of pharmaceutical executive and clinical research experience, predominantly at Johnson & Johnson, where she assumed broad end-to-end development leadership roles in medical marketing, full clinical development, early development, and translational and biomarker sciences in psychiatry and neurology. She successfully filed NDAs in the US and Europe for risperidone indications in Autism, Adolescent Schizophrenia, Juvenile Bipolar Disorder and Conduct Disorders. She also led Development Teams evaluating compounds for Depression, Neuropathic Pain, Epilepsy, and Migraine Disorder.

She served 3 years as Chief Science and Technology Officer for One Mind for Research, a nonprofit organization launched in May 2012 by Patrick J Kennedy. She orchestrated the launch of One Mind’s seminal programs, Apollo, an informatics research portal and, Gemini, an international TBI/PTSD research program.

As an “intrapreneur” at J&J she established the first Neuroscience Translational Medicine & Integrative Solutions department, and co-founded the first Companion Diagnostics Center of Excellence as well as J&J’s Healthcare Innovation team. She serves on several advisory boards including Brain Canada, Prophase, Pear Therapeutics, PAASP and IMEC for nanoelectronics.

Magali earned her BS in bioengineering from the University of Pennsylvania, an MS in biomedical engineering from Rutgers University, New Jersey, and her MD PhD with distinction in neuroscience from Albert Einstein College of Medicine, New York.

Michael Sullivan

Michael Sullivan
Board Treasurer

Michael C. Sullivan is the Chief of Staff and Head of External Affairs of Point72, L.P. Mr. Sullivan joined the Firm in 2007 after serving as a senior aide to a United States Senator, focusing on telecom, technology, and finance issues and spent several years in the U.S. House of Representatives before that working on similar issues. Before coming to the Hill, Mr. Sullivan was the head of strategic development for a telecommunications focused trade association.

Mr. Sullivan is active in several veterans’ mental health-related efforts and organizations. He helped establish and serves on the Board of the Cohen Veterans Network, an organization working to build a national network of clinics to treat veterans and their family members affected by Post-Traumatic Stress. He also serves on the Board of Cohen Veterans Bioscience, a public charity, which is developing next-generation diagnostics and therapeutics to improve the detection and treatment of trauma-related brain disorders.

Mr. Sullivan is a member of the Executive Committee of Students First New York, a nonprofit organization advocating for educational reform in New York State and is a mentor at NYU’s Creative Destruction Lab, working with early-stage science and deep technology startups. Mr. Sullivan received his B.A. from Vanderbilt University.


Terry FrangiosaTheresa Frangiosa
Board Secretary

Theresa Frangiosa held executive positions in the pharmaceutical industry over a 25 year career before establishing Frangiosa and Associates, LLC in 2013, where she serves as Principal and Chief Executive Officer.  She received her MBA in Pharmaceutical Marketing from St. Joseph’s University.  She is a Dementia patient caregiver and has been active in the Brain Disorder advocacy community for several years.  Theresa also serves on the Board of Living Beyond Breast Cancer.

Douglas HaynesDouglas Haynes
Board Member

Doug Haynes formerly served as the President of Point72 Asset Management, L.P., originally joining the Firm as Managing Director of Human Capital in February 2014. Prior to joining Point72, Mr. Haynes was a Director at McKinsey & Company. Before joining McKinsey in 1992, Mr. Haynes worked for the Central Intelligence Agency and then GE’s advanced materials business, which is now part of Sabic International.

Mr. Haynes earned a BS summa cum laude in Mechanical Engineering from West Virginia University, and received his MBA at the University of Virginia’s Darden Graduate Business School, where he was a Shermet Scholar.

Mr. Haynes is an active community member, dedicating a significant portion of his efforts to supporting Veterans’ initiatives. In addition to serving on the Board of the Robin Hood Foundation, Mr. Haynes helped launch its Veterans Advisory Board which raised over $12 million to support the increase in veterans returning from Iraq and Afghanistan, and also works with New York-based companies to create more job opportunities for veterans. Mr. Haynes serves on the Corporate Advisory Board of the Darden Graduate School of Business, the Board of the Canterbury School, SingTel’s Technology Advisory Board, and the Board of the Center for Global Enterprise.

Send this to a friend